Search results for " Respiratory System"

showing 10 items of 851 documents

Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study.

2019

Background: Autoimmune chronic spontaneous urticaria (aiCSU) is an important subtype of chronic spontaneous urticaria (CSU) in which functional IgG autoantibodies to IgE or its high-affinity receptor (FcεRI) induces mast cell degranulation and subsequent symptom development. However, it has not been tightly characterized. This study aimed to better define the clinical and immunological features and to explore potential biomarkers of aiCSU. Methods: This was a multinational, multicenter study of 182 CSU patients. The clinical features studied included: urticaria activity and impact (UAS7 and quality of life); autologous serum skin test (ASST); IgG anti-FcεRI and IgG anti-IgE; IgG-anti-thyrop…

0301 basic medicinechronic spontaneous urticariaMaleBasophilIgG autoantibodiesImmunoglobulin EAutoantigensHistamine Releasechemistry.chemical_compound0302 clinical medicineIron-Binding ProteinsImmunology and AllergyChronic UrticariaReceptorAutologous serum skin testbiologyDegranulationMiddle AgedChronic spontaneous urticariaAntibodies Anti-IdiotypicBasophilsmedicine.anatomical_structurePhenotypeAutologous serum skin testautologous serum skin testFemaleSymptom AssessmentHistamineAdultAdolescentImmunologyIodide PeroxidaseAutoimmune Diseases03 medical and health sciencesYoung Adultautoimmune CSUmedicineJournal ArticleHumansAgedAutoantibodiesbusiness.industryReceptors IgEAutoantibodyBasophil activation030104 developmental biology030228 respiratory systemchemistryImmunoglobulin GImmunologyBasophil activation assaysbiology.proteinAutoimmune CSUbusinessbasophil activation assaysBiomarkersAllergyREFERENCES
researchProduct

Component-Resolved Diagnosis of American Cockroach (Periplaneta americana) Allergy in Patients From Different Geographical Areas

2021

Background:Manifestation of respiratory allergy to American cockroach (Periplaneta americana) is prominent in the subtropical and tropical areas. However, co-existing perennial indoor inhalant allergies frequently compromise clinical diagnosis of cockroach allergy, and the analysis of sensitization pattern is limited by the lack ofPeriplanetaallergens widely available for component-resolved diagnostics (CRD).Objective:To evaluate a collection of previously described recombinantPeriplanetaallergens for CRD in cockroach allergy.Methods:A panel of nine recombinantPeriplaneta allergens (Per a 1–5, 7–10) was generated, purified, and subjected to physicochemical characterization by applying circu…

0301 basic medicinecomponent-resolved diagnosisAllergyanimal structuresPeriplaneta americana (Insecta)medicine.disease_causeAmerican cockroachMicrobiology03 medical and health sciences0302 clinical medicineAllergenimmune system diseasesbiology.animalmedicineIn patientSensitizationCockroachbiologyGeneral MedicineRC581-607biology.organism_classificationmedicine.diseaserespiratory tract diseasesBlattella germanica030104 developmental biologymedicine.anatomical_structure030228 respiratory systemCockroach allergycockroach allergyImmunologic diseases. AllergyAmerican cockroachAmerican cockroach ; Blattella germanica ; component-resolved diagnosis ; cockroach allergy ; Periplaneta americana (Insecta) ; InsektenallergiePeriplanetaFrontiers in Allergy
researchProduct

Nitric Oxide System and Bronchial Epithelium: More Than a Barrier

2021

Airway epithelium forms a physical barrier that protects the lung from the entrance of inhaled allergens, irritants, or microorganisms. This epithelial structure is maintained by tight junctions, adherens junctions and desmosomes that prevent the diffusion of soluble mediators or proteins between apical and basolateral cell surfaces. This apical junctional complex also participates in several signaling pathways involved in gene expression, cell proliferation and cell differentiation. In addition, the airway epithelium can produce chemokines and cytokines that trigger the activation of the immune response. Disruption of this complex by some inflammatory, profibrotic, and carcinogens agents c…

0301 basic medicinecyclic guanosine-3′PhysiologyInflammationReviewCell junctionNitric oxideAdherens junction03 medical and health scienceschemistry.chemical_compound0302 clinical medicinenitric oxidePhysiology (medical)medicineQP1-981bronchial epitheliumLungTight junctionnitric oxide synthasesoluble guanylyl cyclaserespiratory systemrespiratory tract diseases030104 developmental biologymedicine.anatomical_structure030228 respiratory systemchemistryExhaled nitric oxideCancer researchRespiratory epithelium5′-monophosphatemedicine.symptomFrontiers in Physiology
researchProduct

Tamoxifen may cause life-threatening angioedema attacks in patients with hereditary angioedema

2016

0301 basic medicinemedicine.medical_specialtyAngioedemaTrigger factorbusiness.industryMEDLINEDermatologymedicine.diseaseDermatology03 medical and health sciences030104 developmental biology0302 clinical medicineInfectious Diseases030228 respiratory systemSeverity of illnessHereditary angioedemamedicineIn patientmedicine.symptombusinessTamoxifenmedicine.drugJournal of the European Academy of Dermatology and Venereology
researchProduct

Proceedings of the 3rd BEAT-PCD Conference and 4th PCD Training School

2018

Abstract Primary ciliary dyskinesia (PCD) is a chronic suppurative airways disease that is usually recessively inherited and has marked clinical phenotypic heterogeneity. Classic symptoms include neonatal respiratory distress, chronic rhinitis since early childhood, chronic otitis media, recurrent airway infections leading to bronchiectasis, chronic sinusitis, laterality defects with and without congenital heart disease including abnormal situs in approximately 50% of the cases, and male infertility. Lung function deteriorates progressively from childhood throughout life. ‘Better Experimental Approaches to Treat Primary Ciliary Dyskinesia’ (BEAT-PCD) is a network of scientists and clinician…

0301 basic medicinemedicine.medical_specialtyHeart diseaseeducationlcsh:Medicine610 Medicine & healthMeeting ReportGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicinePrimary ciliary dyskinesia360 Social problems & social servicesEpidemiologymedicineotorhinolaryngologic diseasesEarly childhood610 Medicine & healthlcsh:SciencePrimary ciliary dyskinesiaBronchiectasisMultidisciplinarybusiness.industrylcsh:RChronic sinusitisGeneral Medicinemedicine.diseaseChronic respiratory diseaseClinical trial030104 developmental biology030228 respiratory systemFamily medicinelcsh:QbusinessWorking group360 Social problems & social servicesBMC Proceedings
researchProduct

Development of the Angioedema Control Test—A patient‐reported outcome measure that assesses disease control in patients with recurrent angioedema

2019

Background Recurrent angioedema (AE) is an important clinical problem in the context of chronic urticaria (mast cell mediator-induced), ACE-inhibitor intake and hereditary angioedema (both bradykinin-mediated). To help patients obtain control of their recurrent AE is a major treatment goal. However, a tool to assess control of recurrent AE is not yet available. This prompted us to develop such a tool, the Angioedema Control Test (AECT). Methods After a conceptional framework was developed for the AECT, a list of potential AECT items was generated by a combined approach of patient interviews, literature review and expert input. Subsequent item reduction was based on impact analysis, inter-it…

0301 basic medicinemedicine.medical_specialtyImmunologyValidityContext (language use)Bradykinin03 medical and health sciences0302 clinical medicinemedicineContent validityHumansImmunology and AllergyPatient Reported Outcome MeasuresAngioedemaRetrospective StudiesRecallAngioedemabusiness.industryReproducibility of Resultsmedicine.diseaseDisease control030104 developmental biology030228 respiratory systemHereditary angioedemaPhysical therapyPatient-reported outcomemedicine.symptombusinessAllergy
researchProduct

Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme …

2020

Bradykinin (BK)-mediated angioedema (AE) states are rare acquired or hereditary conditions involving localized edema of the subcutaneous and submucosal tissues. Citrated plasma from healthy volunteers or patients with hereditary angioedema (HAE) with normal level of C1-inhibitor (C1-INH) was used to investigate pathways of BK formation and breakdown relevant to AE physiopathology. The half-life of BK (100 nM) added to normal plasma was 34 s, a value that was increased ~12-fold when the angiotensin converting enzyme (ACE) inhibitor enalaprilat (130 nM) was added (enzyme immunoassay measurements). The BK half-life was similarly increased ~5-fold following 2 daily oral doses of enalapril malea…

0301 basic medicinemedicine.medical_specialtykallikreinsPlasminBradykininTissue plasminogen activator03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicineB2 receptorsOriginal ResearchplasminFactor XIIlcsh:R5-920tissue plasminogen activatorAngioedemabiologyhereditary angioedema with normal C1 inhibitor levelAngiotensin-converting enzymeGeneral MedicineKallikreinmedicine.disease030104 developmental biologyEndocrinology030228 respiratory systemchemistryHereditary angioedemabiology.proteinMedicinemedicine.symptombradykininlcsh:Medicine (General)medicine.drugFrontiers in Medicine
researchProduct

Could allergen-specific immunotherapy benefit from the use of nanocarriers?

2016

Allergen-specific immunotherapy: challenges The total number of people suffering from allergic diseases increased dramatically during recent decades. Allergic reactions of the immediate type (type I hypersensitivity reactions according to classification by Coombs and Gell) involve an overreaction of the immune system and the formation of IgE

0301 basic medicinemedicine.medical_treatmentBiomedical EngineeringMedicine (miscellaneous)BioengineeringDevelopmentImmunoglobulin E03 medical and health sciencesDrug Delivery Systems0302 clinical medicineImmune systemmedicineHumansGeneral Materials ScienceAntigen deliverybiologybusiness.industrySpecific immunotherapyImmunotherapyAllergensmedicine.diseaseNanomedicine030104 developmental biology030228 respiratory systemDesensitization ImmunologicImmunologybiology.proteinNanoparticlesNanocarriersbusinessType I hypersensitivityNanomedicine
researchProduct

Single-Cell Transcriptional Profiling of Cells Derived From Regenerating Alveolar Ducts

2020

Lung regeneration occurs in a variety of adult mammals after surgical removal of one lung (pneumonectomy). Previous studies of murine post-pneumonectomy lung growth have identified regenerative “hotspots” in subpleural alveolar ducts; however, the cell-types participating in this process remain unclear. To identify the single cells participating in post-pneumonectomy lung growth, we used laser microdissection, enzymatic digestion and microfluidic isolation. Single-cell transcriptional analysis of the murine alveolar duct cells was performed using the C1 integrated fluidic circuit (Fluidigm) and a custom PCR panel designed for lung growth and repair genes. The multi-dimensional data set was …

0301 basic medicinewarburg effectAngiogenesisglucose metabolismmedicine.medical_treatmentPopulationCellBiology03 medical and health sciencesPneumonectomy0302 clinical medicineAlveolar ductSingle-cell analysismedicinemetabolic reprogrammingeducationaerobic glycolysisOriginal ResearchLaser capture microdissectionlcsh:R5-920education.field_of_studyLungGeneral MedicineCell biology030104 developmental biologymedicine.anatomical_structure030228 respiratory systemMedicinecholangiocarcinomalcsh:Medicine (General)Frontiers in Medicine
researchProduct

Physical capacity in performing daily activities is reduced in scleroderma patients with early lung involvement

2015

Background and Aims Patients with systemic sclerosis (SSc) often complain reduced capacity at submaximal exercise; conversely, physical capacity in performing daily duties has never been measured in SSc. The aim of this study is to evaluate this performance and its correlates, in patients with SSc compared with healthy controls, in a free-living setting. Methods Twenty-seven outpatients with stable SSc and 11 controls were recruited. Physical activity was assessed by portable multiple sensor device (SenseWear Armband) worn for at least 6 days. Physical activity duration (PAD; in minutes) for non-sedentary activities and physical activity level (PAL = total daily energy/resting energy expend…

030203 arthritis & rheumatologyPulmonary and Respiratory MedicineSpirometrymedicine.medical_specialtyActivities of daily livingmedicine.diagnostic_testbusiness.industrymedicine.diseasePhysical activity levelScleroderma03 medical and health sciences0302 clinical medicine030228 respiratory systemDLCOInternal medicinemedicinePhysical therapyCardiologyImmunology and AllergyResting energy expenditurebusinessBioelectrical impedance analysisBody mass indexGenetics (clinical)The Clinical Respiratory Journal
researchProduct